BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:307@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20240111T120000 DTEND;TZID=Europe/Helsinki:20240111T130000 DTSTAMP:20240104T071258Z URL:https://inflames.utu.fi/events/professor-of-practice-lecture-timo-lapp alainen/ SUMMARY:Professor of Practice seminar : Timo Lappalainen DESCRIPTION:\n\nJanuary 11th at 12:00\nOn-site event\nLauren 2 auditorium\ , Medisiina D\n\nDI Timo Lappalainen\, who has been the CEO of Orion Corpo ration for 15 years\, has started as an InFLAMES Professor of Practice at the Faculty of Medicine from the beginning of this year. He will give his Professor of Practice seminar Leading a Pharma Company on January 11th fro m 12:00–13:00. Welcome to the seminar and get to know his remarkable car eer and expertise.\n\nCoffee\, tea and sandwiches will be served before th e seminar starting at 11:30. For catering purposes\, please register for t he seminar before 9.1.2024 via the following link: https://link.webropol.c om/s/pop-lappalainen.\n\n\nThe seminar is open for all!\n\nWELCOME!\n\nPro fessor of Practice Timo Lappalainen's journey in the pharmaceutical indust ry spans nearly three decades\, encompassing roles in international market ing\, business development\, finance\, and\, for the last 15 years\, as th e CEO of Orion Corporation. Orion approaches the pharma market with both g eneric products for a broad array of therapies and innovative products foc used on certain oncology and neurology-related diseases. During his tenure at Orion\, Timo and his team were involved in corporate development actio ns\, focused on R&\;D and production assets\, and invested substantial capital in both immaterial and material assets. They were also fortunate t o hire and retain exceptionally qualified professionals who researched\, d eveloped\, manufactured\, and commercialized the innovations of the compan y.\n\nBeyond Orion\, Timo extends his contributions as a board member\, ch air of audit committee\, member of the personnel and renumeration committe e of Kemira Corporation. Kemira\, listed on the main board of Helsinki Nas daq\, specializes in safe\, sustainable chemistries. Additionally\, he ser ves as the Chairman of the Board and chairs the Human Resources Committee at the Finnish Fair Corporation\, responsible for managing the Helsinki Co nvention Center. His involvement extends further as a board member of the Finnish Foundation for Cardiovascular Research.\n\n \;\n\n \; ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/timo- lappalainen-scaled.jpg END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20231029T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD END:VTIMEZONE END:VCALENDAR